Market Cap ₹11312 Cr.
Stock P/E 113.2
P/B 2.9
Current Price ₹138.7
Book Value ₹ 48.1
Face Value 10
52W High ₹140.8
Dividend Yield 0.36%
52W Low ₹ 62.1
Paradeep Phosphates Ltd manufactures, markets, and distributes phosphatic fertilizers and intermediary merchandise in India. The company gives Di-ammonium phosphate and NPK grade fertilizers; ammonium phosphate sulphate; and muriate of potash, ammonia and sulphuric acid, zypmite, and gypsum. It also markets its by product, as a supplement for sulphur deficient soils; phospho-gypsum for soil conditioning in alkaline soils and imports and markets muriate of potash; and provides advertising services, which includes crop seminars, farmers' meetings, distribution of crop and product literature, publicity van campaigns, retailers meet, and education to farmers. The business enterprise’s products are offered thru private and institutional channels. Its formulated fertilizers are marketed beneath the logo name 'NAVRATNA' catering to a number of crops. The business enterprise incorporated in 1981 and is primarily based in Bhubaneswar, India. Paradeep Phosphates Ltd operates as a subsidiary of Zuari Maroc Phosphates Pvt Ltd.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2864 | 4398 | 3644 | 3054 | 3683 | 2595 | 2243 | 2377 | 3844 | 4105 |
Other Income | 6 | 6 | 70 | 19 | 11 | 9 | 30 | 19 | 15 | 35 |
Total Income | 2870 | 4404 | 3714 | 3074 | 3694 | 2604 | 2273 | 2397 | 3859 | 4140 |
Total Expenditure | 2682 | 4027 | 3553 | 3093 | 3427 | 2313 | 2095 | 2230 | 3418 | 3769 |
Operating Profit | 188 | 377 | 160 | -19 | 267 | 291 | 178 | 166 | 440 | 371 |
Interest | 73 | 87 | 80 | 92 | 96 | 82 | 95 | 91 | 82 | 86 |
Depreciation | 47 | 47 | 50 | 47 | 51 | 55 | 58 | 61 | 63 | 65 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 68 | 243 | 30 | -159 | 120 | 154 | 25 | 14 | 296 | 220 |
Provision for Tax | 17 | 62 | 21 | -39 | 31 | 45 | 5 | 8 | 68 | 62 |
Profit After Tax | 51 | 181 | 9 | -119 | 89 | 109 | 20 | 6 | 227 | 159 |
Adjustments | 0 | -0 | 1 | -1 | 0 | 0 | 1 | -1 | 0 | 0 |
Profit After Adjustments | 51 | 180 | 10 | -120 | 89 | 109 | 22 | 5 | 228 | 159 |
Adjusted Earnings Per Share | 0.6 | 2.2 | 0.1 | -1.5 | 1.1 | 1.3 | 0.3 | 0.1 | 2.8 | 1.9 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 3791 | 4358 | 4193 | 5165 | 7859 | 13341 | 11575 | 12569 |
Other Income | 20 | 43 | 35 | 19 | 39 | 91 | 69 | 99 |
Total Income | 3811 | 4400 | 4228 | 5184 | 7898 | 13432 | 11644 | 12669 |
Total Expenditure | 3313 | 3920 | 3733 | 4622 | 7188 | 12540 | 10927 | 11512 |
Operating Profit | 498 | 481 | 495 | 561 | 710 | 892 | 717 | 1155 |
Interest | 159 | 159 | 192 | 111 | 86 | 291 | 366 | 354 |
Depreciation | 62 | 70 | 72 | 83 | 90 | 175 | 211 | 247 |
Exceptional Income / Expenses | -54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 224 | 251 | 230 | 367 | 535 | 426 | 141 | 555 |
Provision for Tax | 73 | 92 | 36 | 143 | 137 | 122 | 41 | 143 |
Profit After Tax | 151 | 159 | 193 | 223 | 398 | 304 | 100 | 412 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 151 | 159 | 193 | 223 | 398 | 304 | 100 | 414 |
Adjusted Earnings Per Share | 2.6 | 2.8 | 3.4 | 3.9 | 6.9 | 3.7 | 1.2 | 5.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -13% | 31% | 22% | 0% |
Operating Profit CAGR | -20% | 9% | 8% | 0% |
PAT CAGR | -67% | -23% | -9% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 100% | NA% | NA% | NA% |
ROE Average | 3% | 11% | 12% | 12% |
ROCE Average | 6% | 11% | 11% | 11% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | 1395 | 1483 | 1604 | 1828 | 2225 | 3505 | 3564 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 288 | 219 | 139 | 113 | 528 | 612 | 677 |
Other Non-Current Liabilities | 4 | 47 | 49 | 113 | 122 | 149 | 194 |
Total Current Liabilities | 2436 | 3879 | 3218 | 2369 | 5053 | 6391 | 5226 |
Total Liabilities | 4124 | 5628 | 5010 | 4423 | 7928 | 10657 | 9661 |
Fixed Assets | 1008 | 1024 | 1214 | 1226 | 1261 | 2872 | 3431 |
Other Non-Current Assets | 269 | 288 | 191 | 259 | 1534 | 770 | 473 |
Total Current Assets | 2847 | 4315 | 3605 | 2938 | 5133 | 7015 | 5757 |
Total Assets | 4124 | 5628 | 5010 | 4423 | 7928 | 10657 | 9661 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 15 | 24 | 19 | 4 | 92 | 538 | 43 |
Cash Flow from Operating Activities | 804 | -920 | 1270 | 1501 | -44 | -2377 | 1437 |
Cash Flow from Investing Activities | 73 | -103 | -143 | -289 | -1099 | -419 | -367 |
Cash Flow from Financing Activities | -868 | 1018 | -1141 | -1124 | 1589 | 2301 | -1022 |
Net Cash Inflow / Outflow | 9 | -5 | -15 | 87 | 446 | -495 | 48 |
Closing Cash & Cash Equivalent | 24 | 19 | 4 | 92 | 538 | 43 | 91 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 2.62 | 2.76 | 3.36 | 3.88 | 6.92 | 3.73 | 1.23 |
CEPS(Rs) | 3.69 | 3.98 | 4.62 | 5.33 | 8.5 | 5.89 | 3.81 |
DPS(Rs) | 0 | 1 | 1.21 | 0 | 0 | 0.5 | 0.5 |
Book NAV/Share(Rs) | 24.25 | 25.77 | 27.87 | 31.76 | 38.67 | 43 | 43.71 |
Core EBITDA Margin(%) | 12.59 | 10.06 | 10.96 | 10.33 | 8.4 | 5.95 | 5.47 |
EBIT Margin(%) | 10.08 | 9.42 | 10.05 | 9.1 | 7.77 | 5.33 | 4.28 |
Pre Tax Margin(%) | 5.89 | 5.77 | 5.48 | 6.98 | 6.7 | 3.17 | 1.19 |
PAT Margin (%) | 3.97 | 3.65 | 4.61 | 4.25 | 4.99 | 2.26 | 0.84 |
Cash Profit Margin (%) | 5.59 | 5.26 | 6.34 | 5.84 | 6.12 | 3.56 | 2.62 |
ROA(%) | 3.65 | 3.26 | 3.63 | 4.73 | 6.45 | 3.27 | 0.98 |
ROE(%) | 10.79 | 11.05 | 12.52 | 13.01 | 19.66 | 10.62 | 2.83 |
ROCE(%) | 11.76 | 10.45 | 9.91 | 13.69 | 15.03 | 10.78 | 6.46 |
Receivable days | 184.15 | 178.3 | 195.48 | 114.84 | 47.01 | 62.3 | 98.8 |
Inventory Days | 63.42 | 87.17 | 108.83 | 68.73 | 72.91 | 61.47 | 62.71 |
Payable days | 87.54 | 77.85 | 93.85 | 49.69 | 28.75 | 20.75 | 17.63 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 13.47 | 54.14 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 1.17 | 1.52 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0.99 | 0.75 |
EV/Net Sales(x) | 0.63 | 0.84 | 0.68 | 0.34 | 0.37 | 0.65 | 0.8 |
EV/Core EBITDA(x) | 4.83 | 7.65 | 5.8 | 3.09 | 4.13 | 9.66 | 12.95 |
Net Sales Growth(%) | 0 | 14.95 | -3.79 | 23.18 | 52.16 | 69.76 | -13.23 |
EBIT Growth(%) | 0 | 7.29 | 2.61 | 13.43 | 29.84 | 15.61 | -29.35 |
PAT Growth(%) | 0 | 5.56 | 21.55 | 15.55 | 78.46 | -23.66 | -67.16 |
EPS Growth(%) | 0 | 5.56 | 21.55 | 15.55 | 78.46 | -46.06 | -67.17 |
Debt/Equity(x) | 1.33 | 2.11 | 1.43 | 0.68 | 1.33 | 1.32 | 1.12 |
Current Ratio(x) | 1.17 | 1.11 | 1.12 | 1.24 | 1.02 | 1.1 | 1.1 |
Quick Ratio(x) | 0.9 | 0.75 | 0.79 | 0.86 | 0.56 | 0.75 | 0.75 |
Interest Cover(x) | 2.4 | 2.58 | 2.2 | 4.29 | 7.25 | 2.46 | 1.38 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 1.13 | 0.74 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 56.1 | 56.1 | 56.1 | 56.08 | 56.08 | 56.08 | 56.08 | 56.08 | 56.05 | 56.05 |
FII | 4.74 | 5.1 | 5.26 | 5.57 | 5.08 | 1.63 | 1.9 | 2.05 | 5.4 | 7.18 |
DII | 20.74 | 21.77 | 22.49 | 23.56 | 22.03 | 24.6 | 26.83 | 27.09 | 25.54 | 24.44 |
Public | 18.42 | 17.02 | 16.15 | 14.78 | 16.81 | 17.68 | 15.18 | 14.78 | 13 | 12.33 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 | 45.69 |
FII | 3.86 | 4.16 | 4.28 | 4.54 | 4.14 | 1.33 | 1.55 | 1.67 | 4.4 | 5.85 |
DII | 16.89 | 17.74 | 18.32 | 19.2 | 17.95 | 20.05 | 21.86 | 22.07 | 20.82 | 19.92 |
Public | 15.01 | 13.86 | 13.15 | 12.04 | 13.69 | 14.41 | 12.37 | 12.04 | 10.6 | 10.05 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 81.45 | 81.45 | 81.45 | 81.47 | 81.47 | 81.47 | 81.48 | 81.48 | 81.52 | 81.52 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About